ASRM Releases Congressional Scorecard
October 16, 2024
For immediate release
“While we do not endorse in candidate races, we have gotten many requests from our members as they are working to make their own decisions about Congressional elections. Given the high level of salience for reproductive issues in this Congress, we felt it was important to respond to that need,” said Sean Tipton, ASRM’s Chief Advocacy and Policy Officer. Tipton added, “It is our hope that this guide not only provides important information to our members but further spurs their engagement in this year’s historic elections, now only weeks away.”
The scorecard is designed to be clear and easy to follow. Each state’s congressional delegation is listed alphabetically and their stands on bills and resolutions important to ASRM are shown, with indications as to whether the member of Congress shared or opposed ASRM’s position. Some legislation ASRM has not taken an official position on, but which may be relevant to some ASRM members, is also listed.
The Congressional scorecard is available on the ASRM website here
- Opportunities to engage with voters in states where reproductive rights are on the ballot
- A policy update from the Office of Public Affairs in the Spotlight Theater (Monday, October 21 at 1:30 p.m.)
- A Spotlight Theater presentation from the inaugural PRIMED Cohort (Tuesday, October 22 at 10 a.m.) and the chance to learn more and apply for 2025
- A celebration of the passage of the new California IVF insurance mandate, bringing the total number of Americans with improved coverage to 60 million, in the Spotlight Theater at 12:20 following the PRIMED Cohort’s presentation
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as wellASRM Hosts Briefing on New Fertility Benefits for Members of Congress and Congressional Staff
ASRM hosts a Capitol Hill briefing to raise awareness of new fertility benefits for Congress members and staff, highlighting expanded coverage for IVF and fertility treatments.
ASRM Applauds Passage of Reproductive Rights Ballot Measures in 7 States
ASRM applauds reproductive rights measures passed in 7 states, protecting access to reproductive care. Support remains strong nationwide, as ASRM advocates forward.
ASRM Launches its Clinical Embryology Learning Laboratory program in Collaboration with SRBT, with the Support of CooperSurgical, Inc.
ASRM launches the Clinical Embryology Learning Laboratory program with SRBT and CooperSurgical, offering advanced training for embryologists. Enrollment opens July 2025.
ASRM Congress & Expo is Underway
The ASRM Congress & Expo is underway in Denver through Wednesday, October 23.
The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Legally Speaking Column
Legally Speaking is a column highlighting recent court decisions affecting the assisted reproductive technologies and the families they create, written by Susan L. Crockin, J.D. and guest authors who offer unique perspectives and expertise on significant legal topics.
Topic Resources
Changes Ahead: Abortion Policy Proposals Affecting Reproductive Medicine
In January 2023, lawmakers reconvened for the first legislative sessions since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Org. View the ReportStates' Abortion Laws Potential Implications for Reproductive Medicine
This report is the second in a series from the ASRM Center for Policy and Leadership (CPL), a non-partisan think tank. View the ReportThe Potential Impact of States’ Abortion Trigger Laws on Reproductive Medicine
In thirteen states, so-called “trigger” laws have and are set to take effect which ban or severely restrict abortion care. View the ReportASRM Advocacy
The U.S. Supreme Court’s opinion in Dobbs v. Jackson Women’s Health Organization overturned the nearly 50-year precedent set by Roe v. Wade. See what ASRM is advocatingTake Action Now!
Like you, ASRM is extremely concerned over the decision from the Supreme Court to overturn Roe v. Wade and its impact. Take ActionTopic Resources
Advocacy in Action: November 2024
A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members. Read about Advocacy in ActionASRM Hosts Briefing on New Fertility Benefits for Members of Congress and Congressional Staff
ASRM hosts a Capitol Hill briefing to raise awareness of new fertility benefits for Congress members and staff, highlighting expanded coverage for IVF and fertility treatments.
View the Press ReleaseASRM Today: Equity, Access, and Innovation, Episode Eight: ASRM 2024 Preview Part Two
Explore key sessions at ASRM 2024, including mental health in fertility care, male infertility research, and equitable contraceptive access. Join the discussions in Denver. Listen to the EpisodeASRM Today: Equity, Access, and Innovation, Episode Seven: ASRM 2024 Preview Part One
Preview the ASRM 2024 Congress with insights on postgraduate courses covering fertility education, innovation, and increasing access to reproductive care. Listen to the EpisodeASRM Today: Equity, Access, and Innovation, Episode Six: Patient Education
This episode explores the importance of inclusive, plain-language patient education, helping patients understand diagnoses and treatment options. Listen to the EpisodeASRM Announces FY25 Patient Advocacy Grant Awardees
Congratulations to the Newest Grant Recipients! View more information about the patient advocacy grantAdvocacy in Action: September 2024
A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members. Read about Advocacy in ActionFertility and Sterility On Air - Live from ESHRE 2024: Part 1
Discover the impact of embryo expansion post-biopsy and freezing time standardization on live births in this episode from ESHRE 2024. Listen to the EpisodeASRM Today: Equity, Access, and Innovation, Episode Two: Access
Today on the show, part two of our series on equity, access, and innovation, and what that means to reproductive medicine. Listen to the EpisodeASRM Today: Equity, Access, and Innovation, Episode One: Equity
We're joined by renowned experts Dr. Paula Amato and Dr. Jennifer Kawwass to discuss their perspectives on equity and explore the barriers that currently exist. Listen to the EpisodeAdvocacy in Action: June 2024
A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members. Read about Advocacy in ActionEthical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)
Telemedicine has the potential to increase access to and decrease the cost of care. View the Committee OpinionAlabama Supreme Court Rules Frozen Embryos are “Unborn Children” and admonishes IVF’s “Wild West” treatment
Legally Speaking™ on presenting facts and reflecting on the impact and potential implications of legal developments in ART. View the ColumnJune 2023 ASRM Policy Briefing
Find out what the Office of Public Affairs has been doing to influence access to care and reproductive medicine legislation. View the videoCross-border reproductive care: an Ethics Committee opinion (2022)
Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care. View the Ethics Committee DocumentReproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)
Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. View the Committee opinionDisparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021)
In the United States, economic, racial, ethnic, geographic, and other disparities prevent access to fertility treatment and affect treatment outcomes. View the Committee OpinionAccess to fertility treatment irrespective of marital status, sexual orientation, or gender identity: an Ethics Committee opinion (2021)
Individuals and couples should have access to fertility services irrespective of marital status, sexual orientation, or gender identity. View the Committee OpinionAccess to Care Special Interest Group (ATCSIG)
The Access To Care Special Interest Group's purpose is to foster the growth of knowledge among the ASRM membership and the medical community regarding the unmet needs that exist today in access to reproductive care Learn more about the Special Interest GroupExploring Access to Care for Marginalized Communities Course
Enhance your skills and contribute to reducing healthcare disparities for marginalized communities. Learn more about the Exploring Access to Care for Marginalized Communities CourseWhat support for IVF looks like
Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow. View the advocacy resourceIt takes more than one
Why IVF patients often need multiple embryos to have a baby View the advocacy resourceOversight of IVF in the US
In the US, medical care is regulated by a complex and comprehensive network of federal and state regulations and professional oversight. View the advocacy resourceAdvocacy Resources
ASRM has prepared resources to help explain and advocate for reproductive rights and the continuation of in vitro fertilization and other fertility treatments. View the advocacy resourcesPatient Advocacy Grant
The ASRM Patient Advocacy Grants Program awards funds to patient advocacy organizations to support advocacy efforts and educational programs for patients. View more information about the patient advocacy grantTopic Resources
Fertility and Sterility On Air - TOC: October 2024
Explore the latest in reproductive medicine with Fertility and Sterility On Air. Topics include ovarian tissue cryopreservation, DuoStim debates, 1PN embryos, and ART outcomes. Listen to the EpisodeHormonal Induction of Endometrial Receptivity for Fresh or Frozen Embryo Transfer Part I
Explore Dr. Paulson's insights on endometrial receptivity and hormonal preparation in IVF, egg donation, and surrogacy, highlighting estrogen and progesterone roles. View the ASRMed Talk VideoHormonal Induction of Endometrial Receptivity for Fresh or Frozen Embryo Transfer Part II
Dr. Richard Paulson discusses progesterone administration in IVF, comparing intramuscular and vaginal methods, optimal timing, and recent research findings. View the ASRMed Talk VideoFertility and Sterility On Air - Unplugged: October 2024
Topics include: mechanical contractions and fibroid progression, endometriosis classification and risk of infertility, fertility coverage for military personnel and more. Listen to the EpisodeFertility Care Gets Important Win in California
ASRM celebrates California's SB 729, expanding IVF coverage for same-sex couples and singles, advancing equitable fertility care access.
View the Press ReleaseASRM Today: Equity, Access, and Innovation, Episode Five: Policy Matters
This episode covers ballot measures on reproductive rights, ASRM advocacy efforts, and Vot-ER’s push for civic engagement among healthcare workers ahead of elections. Listen to the EpisodeNation’s Leading Professional Group for Fertility Care Professionals Calls for Passage of Right to IVF Act
ASRM applauds Majority Leader Schumer’s decision to seek reconsideration of the Right to IVF Act.
View the Press ReleaseASRM Today: Equity, Access, and Innovation, Episode Three: Innovation
Explore innovation in reproductive health with ASRM Today. Discover how AI, robotics, and new technologies are transforming fertility care and improving patient outcomes. Listen to the EpisodeFertility and Sterility On Air - Live from ESHRE 2024: Part 1
Discover the impact of embryo expansion post-biopsy and freezing time standardization on live births in this episode from ESHRE 2024. Listen to the EpisodeFertility and Sterility On Air - Live from ESHRE 2024: Part 2
Explore fresh embryo transfers, progesterone elevation, and day-seven embryo utility from experts at ESHRE 2024. Cutting-edge fertility insights await! Listen to the EpisodeFertility and Sterility On Air - ANZSREI 2024 Journal Club Global: "Should Unexplained infertility Go Straight to IVF?"
Join "Fertility and Sterility On Air" for insights from the ANXSREI conference on unexplained infertility, IVF, and expert debates. Listen now at ASRM.org. Listen to the EpisodeThe use of preimplantation genetic testing for aneuploidy: a committee opinion (2024)
PGT-A use in the U.S. is rising, but its value as a routine IVF screening test is unclear, with mixed results from various studies. View the Committee OpinionTrump Calls for IVF Coverage, California Legislature Sends IVF Mandate Bill to Governor
The California General Assembly approved a bill mandating most private health insurance plans to provide coverage for In Vitro Fertilization (IVF).
View the Press ReleaseJournal Club Global from ANZSREI 2024: Debate Unexplained infertility; Straight to IVF?
ANZSREI 2024 debate: Should unexplained infertility go straight to IVF? Experts discuss pros, cons, and alternative treatments. No clear consensus reached. View the VideoGet Vot-ER Ready This National Patient Advocacy Day!
Celebrate National Patient Advocacy Day by boosting civic engagement! Order your free Vot-ER badge to help patients register to vote and promote healthy communities.
View the Press ReleasePerforming MD is not the Doctor of Record
Currently we are billing the performing provider as the service provider and the Doctor of Record as the billing provider. View the AnswerWho to bill for gestational carrier services if intended parents have insurance?
I wanted to inquire about guidelines for billing services to a surrogate’s insurance company if intended parents purchased the insurance coverage. View the AnswerASRM marks World IVF Day by doing what we do best – advocating for access to reproductive health care by calling for a House floor vote on the Right to IVF Act
ASRM observed World IVF Day, the day marking the birth of the world’s first IVF baby in 1978, by continuing its advocacy for improvements in IVF policy.
View the Press ReleaseJournal Club Global: Oral Progestin For Ovulation Suppression During IVF
Live broadcast from the 2024 Midwest Reproductive SymposiumInternational in Chicago, IL View the Video
Order your FREE Vot-ER badge to encourage patients and colleagues to vote!
ASRM) is pleased to announce our partnership with Vot-ER, a grassroots organization dedicated to driving civic engagement among healthcare professionals.
View the Press ReleaseFertility and Sterility On Air - Seminal Article: Ernest Ng and Zhi Chen
June issue Seminal Contribution: a randomized controlled trial studying the use of progestins for ovulation supression in predicted high responders. Listen to the EpisodeASRM Responds to Senate Vote on IVF Bill
ASRM is disappointed that a filibuster prevented the passage of the Right to IVF Act.
View the Press ReleaseASRM Calls for Passage of Family Building Bill
It would increase access to IVF treatments for all Americans, including active-duty service members, veterans, and federal employees.
View the Press Release